Ernesto Duronto (@edurontoFF) profile picture

Cardiologist. Chief, CCU and Teaching and Research Department at Favaloro Foundation. Buenos Aires, Argentina. Professor of Cardiology, Favaloro University

Ciudad Autónoma Buenos Aires
Joined July 2016
Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)Photo by Ernesto Duronto (@edurontoFF)
Ernesto Duronto retweeted
¡Celebramos las 5° Jornada Corazón-Cerebro: El poder del trombo🫀🧠! Cómo cada año, le agradecemos profundamente a cada disertante por su participación y excelencia científica, y a los asistentes que acompañaron con su interés, preguntas y ganas de seguir formándose. ¡Gracias!
1
3
5
145
#ESC2026. Pleasure to share Librexia-ACS results presentatión for the principal investigators with two major leaders in cardilogy field. @gabrielsteg @CMichaelGibson @SAC_54 @CONAREC_ORG @comunidadFAC
4
1
1
25
1,017
Ernesto Duronto retweeted
Presented at #ESCCongress: In patients with atrial fibrillation and intermediate stroke risk, direct oral anticoagulation led to a lower risk of stroke, systemic embolism, major bleeding, or death from cardiovascular causes than no anticoagulation. Full SINGLE-AF trial results: nej.md/4ii61XB Editorial: Anticoagulation for Atrial Fibrillation with a Single Risk Factor for Stroke nej.md/45FR7D4 @escardio
3
115
12
327
47,489
NEW 2026 #ESCGuidelines - Fifth Universal Definition of Myocardial Infarction (2026) 👇 ow.ly/yn8J50ZGofb #ESCCongress
2
364
30
918
74,376
Coronary CT angiography to guide lipid management in an asymptomatic community-based population: RESPECT2 randomised controlled trial ow.ly/ZF6T50ZEJKO #ESCCongress #EJPC #EAPC_ESC #cvPrev @AboyansV @SilCastelletti
34
1
101
5,635
Ernesto Duronto retweeted
Non-invasive diagnosis of left main coronary artery disease in chronic coronary syndrome patients: diagnostic utility of an approach using clinical and ECG stress testing doi.org/10.1093/eurheartj/eh… #CCS #CAD #LM #cardiotwitter @ESC_Journals @escardio
1
27
2
74
9,023
Ernesto Duronto retweeted
JUST OUT @JCardFail Journal of Cardiac Failure! Our review on the latest evidence on pharmacotherapy in #aorticstenosis and #TAVR. Congrats @sunnygoelmd , #TakayukiOnishiMD, et al for leading this tremendous effort! Download for FREE here: sciencedirect.com/science/ar… @DoctorKini @georgedangas @AmithoodaMD @KHERA_MD @NoahMossMD @Jcontreras75 @DLBHATTMD @DrDavidReich @MountSinaiHeart @MountSinaiNYC @IcahnMountSinai
4
40
138
9,602
Ernesto Duronto retweeted
Consenso de la ESC (European Society of Cardiology) 2026, sobre Obstrucción Microvascular Coronaria (o fenómeno de no-reflujo). Lo más sintetizado que puedo: 🟢Fenómeno No-reflow coronario: perfusión tisular miocárdica inadecuada a pesar de la recanalización exitosa de la arteria coronaria epicárdica sin obstrucción mecánica. Frecuente y lo pensamos poco (hasta 60% post infarto con elevación del ST tienen perfusión subóptima). Es un problema microvascular que clínicamente puede evolucionar a falla cardíaca. 🟢 El predictor más importante para no-reflow: tiempo en isquemia (puerta-balón). Ser mujer también es un factor. 🟢 Es un marcador pronóstico importante. Un IMR (index of microvascular resistance) >40 casi triplica el hazard de muerte cardiaca. La hemorragia intramiocárdica triplica muerte. 🟢 Casi ninguna terapia farmacológica cambia el desenlace. Adenosina, nitroprusiato y calcioantagonistas mejoran marcadores angiográficos, no mortalidad. Aspiración de trombo rutinaria no se recomienda (riesgo de EVC). 🟢 Así que el enfoque es: diagnóstico temprano, reducir tiempo en isquemia, Estatina de alta dosis temprana, P2Y₁₂ potente, control de presión, glucemia y factores de riesgo. Es un tema muy interesante. Pueden ver el artículo completo en el canal (t.me/memodiapparticulos).
2
92
321
14,251
Influenza vaccination is associated with reduced incident atrial fibrillation, and lower risk of myocardial infarction and all-cause mortality. Read more in #EHJ 👉 ow.ly/w8hh50ZqVrj @RoccoMontone @ehj_ed
1
16
1
44
4,377
Ernesto Duronto retweeted
The benefits of coffee include lowering the risk of atrial fibrillation, Type 2 diabetes, and lowering blood pressure (J-curve, see summary below) A summary of the data and statement from @American_Heart ahajournals.org/doi/10.1161/…
25
278
21
997
83,144
Ernesto Duronto retweeted
This consensus document from the ESC Working Group on Thrombosis provides practical advice regarding best practice for personalizing DAPT in patients with ACS undergoing PCI. eurointervention.pcronline.c…
42
1
109
9,522
UFH-STEMI trial: In STEMI patients undergoing primary PCI, pretreatment with UFH 70-100 IU/kg at prehospital first medical contact improved infarct-related artery patency without increasing the risk of BARC types 3-5 bleeding. #ACC26 View slides here: clinicaltrialresults.org/wp-…
2
63
3
169
11,853
Congratulations @Drroxmehran for being the new @ACCinTouch President. Very well deserved. Many shared readings. Always a pleasure.
1
4
370
Ernesto Duronto retweeted
Early surgery in asymptomatic patients with very severe aortic stenosis led to a lower risk of a composite of operative mortality or death from cardiovascular causes at 10 years than conservative care. Full RECOVERY trial results: nejm.org/doi/full/10.1056/NE…
6
155
10
486
61,792
Ernesto Duronto retweeted
Safety of Catheter Ablation compared with Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomised Trials #OpenAccess @MelbourneEPdoc @DrJasonAndrade @drjohnm @epfellow heartrhythmjournal.com/artic…
1
16
38
3,778
Ernesto Duronto retweeted
REHEALTH AF: first prospective study of ablation vs no ablation in pts ≥80 w/ #AFib. Ablation improved functional & structural outcomes; prognostic benefit emerged after multivariable adjustment. jacc.org/doi/10.1016/j.jacep… #JACCCEP #epAblation
1
50
2
98
23,879
Ernesto Duronto retweeted
This state-of-the-art review outlines current evidence on the mechanisms, prevalence, clinical relevance, and management of TAVI thrombosis and highlights ongoing clinical trials investigating this condition. eurointervention.pcronline.c…
95
237
17,893
Ernesto Duronto retweeted
Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis. Read more in EHJ. ow.ly/l9mW50YljMj #EHJ #cardiotwitter #aspirin #aortic #stenosis #lipoprotein(a) @ESC_journals @escardio #AorticValveDisease
2
40
5
101
13,727
Ernesto Duronto retweeted
Among patients with anterior myocardial infarction, adding low-dose rivaroxaban to dual antiplatelet therapy did not significantly reduce left ventricular thrombus formation at 1 month but increased minor bleeding. ja.ma/4cF3mo4
2
28
3
94
7,990